Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Butyphthalide on Post-Stroke Cognitive Impairment (Be-CLEVER)
NCT05976152Phase 3Recruiting
- Sponsor
- Fudan University
- Start
- Apr 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of butylphthalide in post-stroke cognitive impairment (PSCI), sponsored by Fudan University. Started Apr 2024; status: recruiting.
02
Drugs
butylphthalide
03
Conditions
post-stroke cognitive impairment (PSCI)
Beyond the preview
Go deeper on NCT05976152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05976152.